DK90589A - Anvendelse af chymotrypsin til at goere praekallikrein-aktivatoren uvirksom - Google Patents

Anvendelse af chymotrypsin til at goere praekallikrein-aktivatoren uvirksom

Info

Publication number
DK90589A
DK90589A DK090589A DK90589A DK90589A DK 90589 A DK90589 A DK 90589A DK 090589 A DK090589 A DK 090589A DK 90589 A DK90589 A DK 90589A DK 90589 A DK90589 A DK 90589A
Authority
DK
Denmark
Prior art keywords
chymotrypsin
preparations
preekallikrein
make
immobilised
Prior art date
Application number
DK090589A
Other languages
English (en)
Other versions
DK90589D0 (da
Inventor
Yendra Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of DK90589D0 publication Critical patent/DK90589D0/da
Publication of DK90589A publication Critical patent/DK90589A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK090589A 1988-02-26 1989-02-24 Anvendelse af chymotrypsin til at goere praekallikrein-aktivatoren uvirksom DK90589A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0049488A AT391810B (de) 1988-02-26 1988-02-26 Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators

Publications (2)

Publication Number Publication Date
DK90589D0 DK90589D0 (da) 1989-02-24
DK90589A true DK90589A (da) 1989-08-27

Family

ID=3492093

Family Applications (1)

Application Number Title Priority Date Filing Date
DK090589A DK90589A (da) 1988-02-26 1989-02-24 Anvendelse af chymotrypsin til at goere praekallikrein-aktivatoren uvirksom

Country Status (9)

Country Link
US (2) US5094949A (da)
EP (1) EP0330647B1 (da)
JP (1) JPH07116052B2 (da)
AT (2) AT391810B (da)
CA (1) CA1338499C (da)
DE (1) DE58905495D1 (da)
DK (1) DK90589A (da)
ES (1) ES2059826T3 (da)
FI (1) FI93696C (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
ES2261977T3 (es) * 2002-11-25 2006-11-16 Octapharma Ag Fraccion de albumina derivada de plasma empobrecido en precalicreina.
ES2221817B1 (es) * 2004-07-26 2005-10-01 Probitas Pharma, S.A. "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas".
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1390541A (en) * 1971-04-14 1975-04-16 Otsuka Kagaku Yakuhin Anti-inflammatory compositions
DE2835843A1 (de) * 1978-08-16 1980-02-28 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung
US4272521A (en) * 1979-07-16 1981-06-09 Cutter Laboratories, Inc. Purified immune serum globulin
US4251510A (en) * 1979-08-15 1981-02-17 Cutter Laboratories, Inc. Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
US4608253A (en) * 1982-05-31 1986-08-26 Mochida Pharmaceutical Co., Ltd. Process for removing immune complex in blood by use of the immobilized pepsin
AT376367B (de) * 1983-03-16 1984-11-12 Immuno Ag Verfahren zur herstellung von therapeutisch verabreichbaren, in endbehaeltern abgefuellten plasmaderivaten
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
AT390560B (de) * 1986-05-30 1990-05-25 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators

Also Published As

Publication number Publication date
US5324628A (en) 1994-06-28
AT391810B (de) 1990-12-10
DK90589D0 (da) 1989-02-24
FI93696C (fi) 1995-05-26
ATA49488A (de) 1990-06-15
US5094949A (en) 1992-03-10
ES2059826T3 (es) 1994-11-16
FI890907A0 (fi) 1989-02-24
EP0330647B1 (de) 1993-09-08
FI890907L (fi) 1989-08-27
FI93696B (fi) 1995-02-15
EP0330647A2 (de) 1989-08-30
ATE94071T1 (de) 1993-09-15
EP0330647A3 (en) 1990-05-09
DE58905495D1 (de) 1993-10-14
JPH07116052B2 (ja) 1995-12-13
CA1338499C (en) 1996-07-30
JPH01261332A (ja) 1989-10-18

Similar Documents

Publication Publication Date Title
DK0431129T3 (da) Fremgangsmåder til inaktivering af virus i viruskontaminerede farmaceutiske præparater
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DE69019074D1 (de) Verfahren zur Fraktionierung von Plasmaproteinen.
NL970045I1 (nl) Desulfatohirudinen, werkwijze voor hun bereiding en farmaceutische middelen.
NO166303C (no) Fremgangsmaate ved kvantitativ bestemmelse av protein c ogaktivatorpreparat til gjennomfoering av fremgangsmaaten.
DK155500C (da) Fremgangsmaade til fremstilling af blodkoagulationsfremmende praeparater paa basis af humanproteiner
DK93388D0 (da) Lav-virusvarianter, dna- og proteinbestanddele deraf og anvendelse deraf, saerlig til diagnostiske formaal og til fremstilling af immunogene praeparater
ATA117890A (de) Komplexes virales antigen von hiv-1 bindendes rekombinantes protein
DE69005959D1 (de) Verfahren zur Reinigung von menschlichem Serum-Albumin.
ATE165345T1 (de) Sulfonsaeurederivate zur behandlung von viruserkrankungen
DK41590D0 (da) Forbedrede protein c-molekyler samt fremgangsmaade til fremstilling og aktivering af samme
DK90589A (da) Anvendelse af chymotrypsin til at goere praekallikrein-aktivatoren uvirksom
EP0317804A3 (en) Hiv peptides and methods for detection of hiv
ES2165884T3 (es) Preparacion farmaceutica estable que no contiene actividad viral consistente en al menos un 70%, preferiblemente un 90% de inmunoglobulina a humana monomera, y procedimiento de preparacion.
DE50011030D1 (de) Verfahren zur chromatographischen fraktionierung von plasma oder serum, so erhaltene präparate und deren verwendung
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
DK226889A (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
ATE124539T1 (de) Immunogen und seine verwendung zur gewinnung von antikörpern gegen hba1c.
NO890129L (no) Fremgangsmaate ved inaktivering av sykdomsfremkallende materialer i blodplasmaprodukter.
DE3750886D1 (de) Verwendung eines immunglobulinhaltigen Präparates zur Prophylaxe und Therapie von AIDS beim Menschen.
DK131284D0 (da) Fremgangsmaade til inaktivering af stoffer,der foraarsager uforenelighedsreaktioner
DE59310073D1 (de) Verfahren zur Inaktivierung von Viren in Präparationen von Proteinen
DE68919697D1 (de) Katalytische hydrofluorierung von alkenen.
DK0445626T3 (da) Funktionel test til bestemmelse af protein S-aktivitet.
DK0497929T3 (da) Præparat til stabilisering af blodplasma under pasteurisering